Form 4: GoodRx Holdings Executive Reports Stock Transactions
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.
Summary
- On July 15, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., filed a Form 4.
- The filing details transactions involving Class A Common Stock and Restricted Stock Units.
- Nabiey acquired 2,606 shares of Class A Common Stock through the vesting of Restricted Stock Units.
- Nabiey also disposed of 930 shares of Class A Common Stock at a price of $7.71.
- Following these transactions, Nabiey directly owns 135,489 shares of Class A Common Stock and 5,212 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 04/15/2021 | 19% of restricted stock units vested |
| 07/15/2024 | Date of transaction and filing of Form 4; vesting of 2,606 restricted stock units; disposal of 930 shares at $7.71 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.